Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-026507
Filing Date
2023-05-02
Accepted
2023-05-02 16:28:55
Documents
1
Period of Report
2023-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3461
  Complete submission text file 0001209191-23-026507.txt   4798
Mailing Address 1177 IDAHO STREET REDLANDS CA 92374
Business Address 1177 IDAHO STREET REDLANDS CA 92374 858-483-0024
GENELUX CORP (Issuer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address
Thomas John (Reporting) CIK: 0001939103 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41599 | Film No.: 23879540